Origin ID : SR172;
Automatic exact mappings (from CISMeF team)
https://www.has-sante.fr/jcms/p_3383781/fr/degenerescence-maculaire-liee-a-l-age
2022
false
false
false
France
risk factors
signs and symptoms
macular degeneration
Healthy Lifestyle
VEGF inhibitors
vascular endothelial growth factors
photochemotherapy
laser therapy
intravitreal injections
vision disorders
ophthalmology
orthoptics
occupational therapy
consumer health information
macular degeneration
guideline
macular degeneration
Age-Related Macular Degeneration
---
https://www.cosprc.ca/wp-content/uploads/2020/04/Traduction-ACUPO-anti-VEGF_FR_20200422_v3.pdf
2020
Canada
pneumonia, viral
coronavirus infections
guideline
vascular endothelial growth factor a
health planning guidelines
VEGF inhibitors
Injection moulding
injection, nos
injections
pandemics
COVID-19
---
https://www.cosprc.ca/fr/sustained-funding-to-ensure-access-to-anti-vascular-endothelial-growth-factor-drugs-2019/
2019
false
false
false
false
Canada
drug costs
wet macular degeneration
wet macular degeneration
Ranibizumab
Ranibizumab
aflibercept
aflibercept
Bevacizumab
Bevacizumab
macular edema
diabetic retinopathy
wet macular degeneration
insurance, health, reimbursement
canada
retinal diseases
guidelines
VEGF inhibitors
vascular endothelial growth factors
recombinant fusion proteins
receptors, vascular endothelial growth factor
recombinant fusion proteins
receptors, vascular endothelial growth factor
---
